Velocity Vlog: Advances in Merkel Cell Carcinoma - New Treatment Approaches

Submitted by onc_editor on Fri, 01/26/2018 - 16:40

Velocity Vlog: Advances in Merkel Cell Carcinoma - New Treatment Approaches

 

The time is ripe for sharpening awareness of Merkel cell carcinoma (MCC). Recent reports indicate that this form of skin cancer—one far more deadly than melanoma—is growing in incidence as the population ages. Further, recently completed and ongoing clinical trials indicate that MCC is amenable to immunotherapy, and an immune checkpoint inhibitor recently received FDA approval for its treatment. Featuring expert analysis by Dr. Howard L. Kaufman of the Rutgers Cancer Institute, this activity contextualizes updates to the standard of care, relays the latest developments in immunotherapy, and offers insight into best practices for the incorporation of novel agents in your clinical practice.